Oxaprozin NDC 69238-1120

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1120Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1120Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1120-1	69238112001	100 TABLET in 1 BOTTLE (69238-1120-1)Marketed from May 4, 2017
69238-1120-5	69238112005	500 TABLET in 1 BOTTLE (69238-1120-5)Marketed from May 4, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxaprozin
Generic name (nonproprietary): oxaprozin
Active ingredients: Oxaprozin — 600 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208633
Marketing start: May 4, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 69238-1120_b77a2557-2013-46ce-8d87-a25f17be5b89SPL ID b77a2557-2013-46ce-8d87-a25f17be5b89SPL set ID d9b0ca6c-4c53-4f6e-918b-02a8c472a194RxCUI 312132UNII MHJ80W9LRB
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238112001 followed by a unit qualifier and the quantity

Package 69238-1120-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 26, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Oxaprozin tablets are indicated: For relief of the signs and symptoms of osteoarthritis For relief of the signs and symptoms of rheumatoid arthritis For relief of the signs and symptoms of juvenile rheumatoid arthritis Oxaprozin is a non-steroidal anti-inflammatory drug indicated for: Relief of signs and symptoms of Osteoarthritis (OA). (1) Relief of signs and symptoms of Rheumatoid Arthritis (RA). (1) Relief of signs and symptoms of Juvenile Rheumatoid Arthritis (JRA). (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208633

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208633
Product	Strength	Form · route	Labeler	Product NDC
Oxaprozin	Oxaprozin 600 mg/1	TabletOral	Bryant Ranch Prepack	71335-0617